H. Kim Lyerly, M.D.
Recent Publications

Chen M,Wang J,Lu J,Bond MC,Ren XR,Lyerly HK,Barak LS,Chen W. The Anti-Helminthic Niclosamide Inhibits Wnt/Frizzled1 Signaling.,9/22/2009, (-) - Biochemistry Abstract [More ...] Ding X,Mohd AB,Huang Z,Baba T,Bernardini MQ,Lyerly HK,Berchuck A,Murphy SK,Buermeyer AB,Devi GR. MLH1 expression sensitises ovarian cancer cells to cell death mediated by XIAP inhibition.,7/21/2009, (269-77) - British journal of cancer Abstract [More ...] Abernethy AP,Herndon JE 2nd,Wheeler JL,Day JM,Hood L,Patwardhan M,Shaw H,Lyerly HK. Feasibility and acceptability to patients of a longitudinal system for evaluating cancer-related symptoms and quality of life: pilot study of an e/Tablet data-collection system in academic oncology.,6/1/2009, (1027-38) - Journal of pain and symptom management Abstract [More ...] Osada T,Woo CY,McKinney M,Yang XY,Lei G,Labreche HG,Hartman ZC,Niedzwiecki D,Chao N,Amalfitano A,Morse MA,Lyerly HK,Clay TM. Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine.,4/15/2009, (2789-96) - Clinical cancer research : an official journal of the American Association for Cancer Research Abstract [More ...] Osada T,Yang XY,Hartman ZC,Glass O,Hodges BL,Niedzwiecki D,Morse MA,Lyerly HK,Amalfitano A,Clay TM. Optimization of vaccine responses with an E1, E2b and E3-deleted Ad5 vector circumvents pre-existing anti-vector immunity.,2/20/2009, (-) - Cancer gene therapy Abstract [More ...] Cheever MA,Schlom J,Weiner LM,Lyerly HK,Disis ML,Greenwood A,Grad O,Nelson WG. Translational Research Working Group developmental pathway for immune response modifiers.,9/15/2008, (5692-9) - Clinical cancer research : an official journal of the American Association for Cancer Research Abstract [More ...] Abernethy AP,Herndon JE 2nd,Wheeler JL,Patwardhan M,Shaw H,Lyerly HK,Weinfurt K. Improving Health Care Efficiency and Quality Using Tablet Personal Computers to Collect Research-Quality, Patient-Reported Data.,8/28/2008, (-) - Health services research Abstract [More ...] Maecker HT,Hassler J,Payne JK,Summers A,Comatas K,Ghanayem M,Morse MA,Clay TM,Lyerly HK,Bhatia S,Ghanekar SA,Maino VC,Delarosa C,Disis ML. Precision and linearity targets for validation of an IFNgamma ELISPOT, cytokine flow cytometry, and tetramer assay using CMV peptides.,3/17/2008, (9) - BMC immunology Abstract [More ...] Osada T,Chong G,Tansik R,Hong T,Spector N,Kumar R,Hurwitz HI,Dev I,Nixon AB,Lyerly HK,Clay T,Morse MA. The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients.,1/10/2008, (-) - Cancer immunology, immunotherapy : CII Abstract [More ...] Hobeika A,Osada T,Serra D,Peplinski S,Hanson K,Tanaka Y,Niedzwiecki D,Chao N,Rizzieri D,Lyerly H,Clay T,Morse M. Detailed analysis of cytomegalovirus (CMV)-specific T cells expanded for adoptive immunotherapy of CMV infection following allogeneic stem cell transplantation for malignant disease.,1/1/2008, (289-302) - Cytotherapy Abstract [More ...]

---

NOTE: For more publications on this researcher, please visit Pubmed - A service of the National Library of Medicine and the National Institutes of Health.